3 Clinical-Stage Biotech Stocks with Explosive Upside Potential in 2015

Source: Flickr via Idaho National Laboratory.Biotech stocks have the uncanny ability to absolutely crush it following a positive clinical or regulatory catalyst. And this trend has been especially pronounced among standout clinical-stage companies over the past few years.In 2014, for instance, we saw bluebird bio more than triple in share price after reporting positive early- to mid-stage study results for […]